Solana Co

Solana Co (HSDT) Stock Analysis

$2.340

-0.087 (-3.70%)At close

Loading chart…
High
2.440
Open
2.420
VWAP
2.35
Vol
395.34K
Mkt Cap
2.91M
Low
2.260
Amount
927.74K
EV/EBITDA, TTM
-1.01

Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.

AI analysis of Solana Co (HSDT)

buy

Helius Medical Technologies Inc (HSDT) is a good buy right now, trading at $2.34 with a recent RSI of 71.625 indicating strong momentum. The stock has shown a significant 41.82% increase over the past 20 days, suggesting positive short-term performance. Additionally, analysts project a price target of $3 to $4, indicating potential upside of 28.0% to 70.6%. However, the main risk is the company's negative earnings with a forward P/E of 0 and a recent quarterly loss of $0.05 per share, which could affect investor sentiment.

Analyst Ratings (1)

Buy
1 Buy
0 Hold
0 Sell
Current: 2.34
Low
Average
High

B. Riley

2026-04-23

Price Target

$3

Buy

Maxim Group

2024-10-16

Price Target

Hold

Roth MKM

2024-03-05

Price Target

$24

Strong Buy

Maxim Group

2022-12-20

Price Target

$50

Strong Buy

Roth Capital

2022-08-23

Price Target

$250

Strong Buy

Valuation Metrics

The current forward P/E ratio for Solana Co (HSDT) is 0.00, compared to its 5-year average forward P/E of -2.37.

Forward P/E

Fair
5Y Average P/E
-2.37
Current P/E
0.00
Overvalued
4.25
Undervalued
-9.00

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-0.90
Current EV/EBITDA
-1.01
Overvalued
12.85
Undervalued
-14.64

Forward P/S

Fair
5Y Average P/S
48.88
Current P/S
13.36
Overvalued
224.89
Undervalued
-127.13

Alphio AI Price Scenarios for HSDT

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%HSDT

$2.58

Scenario price

B

Base

Base · 50%HSDT

$2.40

Scenario price

B

Bear

Bear · 25%HSDT

$2.06

Scenario price

Whales holding HSDT

V

VR Advisory Services Ltd.

+ HoldingHSDT

-5.11%

3M Return

Events Timeline

2026-06-30 (ET)

07:30:00

Solana Signs MoU with Alatau City for Blockchain Partnership

2026-06-16 (ET)

11:30:00

Hyperscale Data Plans to End Bitcoin Mining in Michigan

08:00:00

Solana Company Rejects Forward Industries Acquisition Proposal

2026-06-15 (ET)

09:30:00

Forward Industries Proposes All-Stock Merger to Solana

2026-04-27 (ET)

11:30:00

Bitcoin Climbs to $79,488 on Strong Institutional Demand

News

HSDT FAQ — answered by Alphio AI

Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders. It operates in the Financials sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).

Helius Medical Technologies Inc (HSDT) is a good buy right now, trading at $2.34 with a recent RSI of 71.625 indicating strong momentum. The stock has shown a significant 41.82% increase over the past 20 days, suggesting positive short-term performance. Additionally, analysts project a price target of $3 to $4, indicating potential upside of 28.0% to 70.6%. However, the main risk is the company's negative earnings with a forward P/E of 0 and a recent quarterly loss of $0.05 per share, which could affect investor sentiment.

1 analysts cover HSDT: 1 rate it Buy, 0 Hold and 0 Sell.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started